![Kristi Elliott](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kristi Elliott
Directeur des opérations chez
CAPRICOR THERAPEUTICS, INC.
Profil
Kristi A. H.
Elliott is currently Chief Operating & Science Officer at Capricor Therapeutics, Inc. since 2021.
Formerly, Dr. Elliott was Senior Director-Stem Cell & Exosome Development at Precigen, Inc. Education includes undergraduate and graduate degrees from Rutgers State University of New Jersey and a doctorate from The Johns Hopkins University School of Medicine.
Postes actifs de Kristi Elliott
| Sociétés | Poste | Début |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Directeur des opérations | - |
Anciens postes connus de Kristi Elliott
| Sociétés | Poste | Fin |
|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | - |
Formation de Kristi Elliott
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capricor Therapeutics, Inc.
 Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
